Fol. Biol. 2001, 47, 211-214
https://doi.org/10.14712/fb2001047060211
New Monoclonal Antibodies Recognizing the p53 Tumour Suppressor Protein Homologue p73
References
1. , V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., Melino, G. (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 188, 1763-1768.
<https://doi.org/10.1084/jem.188.9.1763>
2. , V. D., Catani, M. V., Terrinoni, A., Corazzari, M., Melino, G., Costanzo, A., Levrero, M., Knight, R. A. (1999) Additional complexity in p73: induction by mito- gens in lymphoid cells and identification of two new splic- ing variants epsilon and zeta. Cell Death Differ. 6, 389-390.
<https://doi.org/10.1038/sj.cdd.4400521>
3. Harlow, E., Lane, D. P. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
4. , M., Sidransky, D., Vogelstein, B., Harris, C. C. (1991) p53 mutations in human cancers. Science 253, 49-53.
<https://doi.org/10.1126/science.1905840>
5. , C. A., Marin, M. C., Kaelin, W. G. Jr. (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191-194.
<https://doi.org/10.1038/38298>
6. , M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.
<https://doi.org/10.1016/S0092-8674(00)80540-1>
7. , L. J., Prives, C. (1996) p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
<https://doi.org/10.1101/gad.10.9.1054>
8. , D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16.
<https://doi.org/10.1038/358015a0>
9. , A. J.(1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
<https://doi.org/10.1016/S0092-8674(00)81871-1>
10. , J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342, 705-708.
<https://doi.org/10.1038/342705a0>
11. , Y., Hijikata, M., Takagi, S., Chiba, T., Shimotohno, K. (1999) New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 18, 4993-4998.
<https://doi.org/10.1038/sj.onc.1202817>
12. , A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N. C., Caput, D., McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-nega- tive activities. Mol. Cell. 2, 305-316.
<https://doi.org/10.1016/S1097-2765(00)80275-0>
